144 related articles for article (PubMed ID: 38793589)
1. Development of a Cell Culture Model for Inducible SARS-CoV-2 Replication.
Wang X; Zhu Y; Wu Q; Jiang N; Xie Y; Deng Q
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793589
[TBL] [Abstract][Full Text] [Related]
2. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
[TBL] [Abstract][Full Text] [Related]
3. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies.
Nguyen HT; Falzarano D; Gerdts V; Liu Q
J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580
[TBL] [Abstract][Full Text] [Related]
4. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
He X; Quan S; Xu M; Rodriguez S; Goh SL; Wei J; Fridman A; Koeplinger KA; Carroll SS; Grobler JA; Espeseth AS; Olsen DB; Hazuda DJ; Wang D
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33766889
[TBL] [Abstract][Full Text] [Related]
5. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
[TBL] [Abstract][Full Text] [Related]
6. Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.
Malicoat J; Manivasagam S; Zuñiga S; Sola I; McCabe D; Rong L; Perlman S; Enjuanes L; Manicassamy B
J Virol; 2022 Feb; 96(3):e0183721. PubMed ID: 34851142
[TBL] [Abstract][Full Text] [Related]
7. A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2.
Zhang Y; Song W; Chen S; Yuan Z; Yi Z
Antiviral Res; 2021 Jan; 185():104974. PubMed ID: 33217430
[TBL] [Abstract][Full Text] [Related]
8. Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination.
Herrmann A; Jungnickl D; Cordsmeier A; Peter AS; Überla K; Ensser A
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638527
[TBL] [Abstract][Full Text] [Related]
9. A novel cell culture system modeling the SARS-CoV-2 life cycle.
Ju X; Zhu Y; Wang Y; Li J; Zhang J; Gong M; Ren W; Li S; Zhong J; Zhang L; Zhang QC; Zhang R; Ding Q
PLoS Pathog; 2021 Mar; 17(3):e1009439. PubMed ID: 33711082
[TBL] [Abstract][Full Text] [Related]
10. Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes.
Ye C; Martinez-Sobrido L
Microbiol Spectr; 2022 Dec; 10(6):e0273222. PubMed ID: 36342302
[TBL] [Abstract][Full Text] [Related]
11. Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
Ueno S; Amarbayasgalan S; Sugiura Y; Takahashi T; Shimizu K; Nakagawa K; Kawabata-Iwakawa R; Kamitani W
Virology; 2024 Jul; 595():110068. PubMed ID: 38593595
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 replicon for high-throughput antiviral screening.
Zhang QY; Deng CL; Liu J; Li JQ; Zhang HQ; Li N; Zhang YN; Li XD; Zhang B; Xu Y; Ye HQ
J Gen Virol; 2021 May; 102(5):. PubMed ID: 33956592
[TBL] [Abstract][Full Text] [Related]
13. Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
Liu S; Chou CK; Wu WW; Luan B; Wang TT
J Virol; 2022 Mar; 96(6):e0221621. PubMed ID: 35080424
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
Tanaka T; Saito A; Suzuki T; Miyamoto Y; Takayama K; Okamoto T; Moriishi K
Antiviral Res; 2022 Mar; 199():105268. PubMed ID: 35271914
[TBL] [Abstract][Full Text] [Related]
15. Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors.
Luo Y; Yu F; Zhou M; Liu Y; Xia B; Zhang X; Liu J; Zhang J; Du Y; Li R; Wu L; Zhang X; Pan T; Guo D; Peng T; Zhang H
mBio; 2021 Jan; 12(1):. PubMed ID: 33468688
[TBL] [Abstract][Full Text] [Related]
16. Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis.
Wang L; Guzman M; Muñoz-Santos D; Honrubia JM; Ripoll-Gomez J; Delgado R; Sola I; Enjuanes L; Zuñiga S
Front Cell Infect Microbiol; 2023; 13():1268227. PubMed ID: 37942479
[TBL] [Abstract][Full Text] [Related]
17. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M
Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962
[TBL] [Abstract][Full Text] [Related]
18. A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation.
Kotaki T; Xie X; Shi PY; Kameoka M
Sci Rep; 2021 Jan; 11(1):2229. PubMed ID: 33500537
[TBL] [Abstract][Full Text] [Related]
19. Replication and single-cycle delivery of SARS-CoV-2 replicons.
Ricardo-Lax I; Luna JM; Thao TTN; Le Pen J; Yu Y; Hoffmann HH; Schneider WM; Razooky BS; Fernandez-Martinez J; Schmidt F; Weisblum Y; Trüeb BS; Berenguer Veiga I; Schmied K; Ebert N; Michailidis E; Peace A; Sánchez-Rivera FJ; Lowe SW; Rout MP; Hatziioannou T; Bieniasz PD; Poirier JT; MacDonald MR; Thiel V; Rice CM
Science; 2021 Nov; 374(6571):1099-1106. PubMed ID: 34648371
[TBL] [Abstract][Full Text] [Related]
20. Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis.
Almazán F; Dediego ML; Galán C; Escors D; Alvarez E; Ortego J; Sola I; Zuñiga S; Alonso S; Moreno JL; Nogales A; Capiscol C; Enjuanes L
J Virol; 2006 Nov; 80(21):10900-6. PubMed ID: 16928748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
